Clasificación en acciones
#29054
PT Indofarma Tbk, along with its affiliated entities, is dedicated to the... PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
Precio por acción
$0.00748841
Última sincronización: 2024-07-01
Capitalización bursátil
$23.21M
Comercio PT Indofarma Tbk (INAF)
Precio INAF con Capital del mercado a B
Capitalización de mercado de PT Indofarma Tbk(INAF)
Capitalización bursátil: $23.21M
A fecha de August 2026, PT Indofarma Tbk tiene una capitalización de mercado de $23.21M. Esto convierte a PT Indofarma Tbk en la 29054th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de PT Indofarma Tbk desde 2001 hasta 2026
INAF en comparación con los más populares 5 títulos stocks
| Precio por INAF |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.310T
|
+22,879,229.90%
|
|
|
|
|
$4.632T
|
+19,956,869.71%
|
|
|
|
|
$4.140T
|
+17,838,304.02%
|
|
|
|
|
$3.595T
|
+15,488,600.08%
|
|
|
|
|
$2.845T
|
+12,257,065.57%
|
